Breaking News – Full Federal Court Confirms Patentability of Isolated Genes

by K&L Gates LLP

Yvonne D'Arcy v Myriad Genetics Inc & Anor (5 September 2014)

A five-judge bench of the Full Court of the Federal Court of Australia (Full Court) has today unanimously decided that Myriad Genetics Inc's (Myriad) patent covering the isolated BRCA1 gene (Patent) is patentable subject matter in Australia.

The Full Court elected not to follow the reasoning of the U.S. Supreme Court, when it found in 2013 that certain claims of a closely related U.S. Patent of Myriad were invalid, as the claim to isolated nucleic acid was a claim to a "product of nature" and not patentable subject matter.

The key issue for determination by the Full Court under Australian law was whether the invention in the Patent - which claimed isolated nucleic acids, including isolated DNA and RNA - constitutes a 'manner of manufacture' for the purposes of section 18(1)(a) of the Patents Act 1990 (Cth) (Act). The nucleic acids claimed in the Patent (Invention) are naturally occurring materials that have been 'isolated', which essentially means that they have been extracted from cells obtained from the human body and purged of other biological materials with which they were associated.

At first instance, Justice Nicholas found that the Invention constituted a 'manner of manufacture' and, therefore, the Patent was valid. The Federal Court of Australia (Court), therefore, dismissed the application to revoke the Patent. The Full Court agreed with the trial judge's finding that the Patent was valid and dismissed the appeal.

The Full Court confirmed that the test for whether an invention was a manner of manufacture turned on whether it resulted in an artificial state of affairs providing a new and useful effect that is of economic significance, which is the test set out in the National Research Development Corporation Case (NRDC Case).


The claims of the Patent relate to isolated nucleic acid coding for mutant or polymorphic BRCA1 gene. These mutations in the BRCA1 gene can serve as indicators of a woman's risk of developing breast cancer, among other things.

In the first instance decision, the Court said that there were three considerations that supported its finding that the Invention was a 'manner of manufacture':

  • The Australian High Court has indicated in the NRDC Case that the concept of what constitutes a 'manner of manufacture' has a 'broad sweep', to encompass developments in technology that are, by their nature, often unpredictable.
  • Because the DNA and RNA in the Invention does not naturally exist outside of human cells – but requires human intervention in order to exist – it is an artificially created state of affairs.
  • It would be a very odd result if a person whose skill and effort culminated in the isolation of a DNA sequence could not be independently rewarded by grant of a patent because the isolated sequence was held to be inherently non-patentable.

At first instance the Court did affirm that naturally occurring DNA and RNA as they exist inside the cells of a human body are not patentable. However, it also pointed out that the Court was not required to ask whether a composition of matter is a "product of nature" for the purpose of deciding whether or not it constitutes patentable subject matter.

The Full Court has reiterated that view in delivering its reasons in Court, finding that: "…the isolated nucleic acid, including cDNA, has resulted in an artificially created state of affairs for economic benefit. The claimed product is properly the subject of letters patent."

Next Steps – Further Appeal Possible
Either party may seek special leave to appeal the Full Court's decision to the High Court of Australia.

Impact on Gene Patenting
Unless this decision is successfully appealed, it will stand to affirm that isolated genetic material of the type in the Patent can be a manner of manufacture capable of patent protection. More broadly, this decision appears to support the proposition that, where human intervention is required to isolate an otherwise naturally occurring substance or organism from its usual surroundings and chemical associations, the isolated material could constitute patentable subject matter.

We have also previously written about the first instance decision and its potential impact of this dispute on gene patenting here.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© K&L Gates LLP | Attorney Advertising

Written by:

K&L Gates LLP

K&L Gates LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.